PCI Biotech half-year interim 2025 report - Candlesense

PCI Biotech half-year interim 2025 report

(PCIB) Oslo (Norway), 29 August 2025 – PCI Biotech (OSE: PCIB), today announces its half-yearly 2025 interim report. Please find enclosed the interim report and presentation.